A Phase 2 Trial of Sunitinib in Patients with Advanced Non–clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

A Phase 2 Trial of Sunitinib in Patients with Advanced Non–clear Cell Renal Cell Carcinoma

Published:2012-12 Issue:6 Volume:62 Page:1013-1019
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Tannir Nizar M.,Plimack Elizabeth,Ng Chaan,Tamboli Pheroze,Bekele Nebiyou B.,Xiao Lianchun,Smith Lisa,Lim Zita,Pagliaro Lance,Araujo John,Aparicio Ana,Matin Surena,Wood Christopher G.,Jonasch Eric

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Cancer statistics, 2012;Siegel;CA: Cancer J Clin,2012

2. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

3. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

4. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N Engl J Med,2007

5. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial;Escudier;Lancet,2007

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma;Journal of Clinical Oncology;2024-09-10

2. Current Status and Challenges in Rare Genitourinary Cancer Research and Future Directions;Current Oncology Reports;2024-06-07

3. Radiation Therapy for the Management of Renal Medullary Carcinoma: A Multi-Case Study;Clinical Genitourinary Cancer;2024-06

4. Papillary Renal Cell Carcinoma: Current Evidence and Future Directions;Kidney Cancer;2024-05-07

5. Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update;Journal of Cancer Research and Clinical Oncology;2024-04-09